FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Telmisartan and Amlodipine (Twynsta) Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Boehringer Ingelheim Pharmaceuticals, Inc. (New 03/06/2018)

Company Contact Information:

Presentation Posting Date Related Information
Telmisartan and Amlodipine (Twynsta) tablets 80mg/10mg, 30 count blister (NDC 0597-0127-37) 03/06/2018 Discontinuation is the result of a business decision made by Boehringer lngelheim Pharmaceuticals, Inc. All other strengths of Twynsta® tablets are still available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English